Literature DB >> 25193010

Health-related quality of life in patients with ankylosing spondylitis: a comprehensive review.

Konstantinos Kotsis1, Paraskevi V Voulgari, Alexandros A Drosos, André F Carvalho, Thomas Hyphantis.   

Abstract

Ankylosing spondylitis (AS) is a complex systemic rheumatological disease which often causes severe disability and impaired quality of life (QoL). We searched the PubMed/MEDLINE electronic database for available literature on QoL and its predictors in patients with AS. Recent evidence indicates that AS patients have poorer QoL compared to the general population, but similar to that of patients with other rheumatological disorders. Disease activity is one of the most powerful predictors of QoL, however latest advances in pharmacological treatment (namely, anti-TNF-α) along with physical exercise can minimize the effects of AS on QoL. Psychological distress symptoms contribute to impaired QoL both directly and indirectly by influencing disease activity. The impact of other psychosocial variables, however, is less studied and more prospective investigations are necessary, which could eventually lead to the development of psychosocial interventions that are personalized to this patient population.

Entities:  

Keywords:  ankylosing spondylitis; anxiety; depression; disease activity; functional limitations; illness perceptions; quality of life

Mesh:

Year:  2014        PMID: 25193010     DOI: 10.1586/14737167.2014.957679

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  22 in total

1.  Real Life Experience of First Course of Anti-TNF Treatment in Ankylosing Spondylitis Patients in Brazil.

Authors:  Marina Amaral de Ávila de Machado; Alessandra Maciel Almeida; Adriana Maria Kakehasi; Francisco de Assis Acurcio
Journal:  Rheumatol Ther       Date:  2016-01-29

2.  Depression/anxiety symptoms in axial spondyloarthritis and psoriatic arthritis patients in Serbia: a pilot study.

Authors:  Sanja Milutinovic; Kristina Veljkovic; Maja Zlatanovic; Goran Radunovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2019-07-15       Impact factor: 2.631

3.  Turkish Version of Evaluation of Ankylosing Spondylitis Quality of Life Questionnaire in Patients With Ankylosing Spondylitis: A Validation and Reliability Study.

Authors:  Nagehan Öncülokur; Dilek Keskin; Yeşim Garip; Hatice Bodur; Kenan Köse
Journal:  Arch Rheumatol       Date:  2018-04-11       Impact factor: 1.472

4.  Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS).

Authors:  Marco Garrido-Cumbrera; Denis Poddubnyy; Laure Gossec; Raj Mahapatra; Christine Bundy; Souzi Makri; Sergio Sanz-Gómez; Laura Christen; Carlos J Delgado-Domínguez; Victoria Navarro-Compán
Journal:  Clin Rheumatol       Date:  2021-01-19       Impact factor: 2.980

5.  Ankylosing spondylitis diagnosis in US patients with back pain: identifying providers involved and factors associated with rheumatology referral delay.

Authors:  Atul Deodhar; Manish Mittal; Patrick Reilly; Yanjun Bao; Shivaji Manthena; Jaclyn Anderson; Avani Joshi
Journal:  Clin Rheumatol       Date:  2016-03-18       Impact factor: 2.980

6.  Does Body Image Affect Quality of Life?: A Population Based Study.

Authors:  Tufan Nayir; Ersin Uskun; Mustafa Volkan Yürekli; Hacer Devran; Ayşe Çelik; Ramazan Azim Okyay
Journal:  PLoS One       Date:  2016-09-20       Impact factor: 3.240

7.  Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3.

Authors:  Karel Pavelka; Alan Kivitz; Eva Dokoupilova; Ricardo Blanco; Marco Maradiaga; Hasan Tahir; Luminita Pricop; Mats Andersson; Aimee Readie; Brian Porter
Journal:  Arthritis Res Ther       Date:  2017-12-22       Impact factor: 5.156

Review 8.  Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system.

Authors:  Elsa How Shing Koy; Pierre Labauge; Athan Baillet; Clément Prati; Hubert Marotte; Yves-Marie Pers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-09       Impact factor: 5.346

9.  A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients.

Authors:  Benjamin Chastek; John White; Damon Van Voorhis; Derek Tang; Bradley S Stolshek
Journal:  Adv Ther       Date:  2016-03-12       Impact factor: 3.845

10.  The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis.

Authors:  Gudrun Rohde; Kari Hansen Berg; Anne Prøven; Glenn Haugeberg
Journal:  BMC Musculoskelet Disord       Date:  2017-08-01       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.